Impact of liposomes as delivery systems in veterinary medicine

Veterinary Research

Volumn 29, Issue 5, 1998, Pages 409-430

  Sallovitz, Juan M ^a   Zonco Menghini, María I ^a   Lanusse, Carlos E ^a  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Delivery system; Liposome; Pharmacokinetics; Therapy

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; ANNAMYCIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; AVIAN REOVIRUS VACCINE; D 99; DAUNORUBICIN; DOXORUBICIN; HEPATITIS A VACCINE; IMMUNOMODULATING AGENT; LIPOSOMAL ANNAMYCIN; LIPOSOMAL NYSTATIN; LIPOSOME; NEWCASTLE DISEASE VACCINE; NYSTATIN; UNCLASSIFIED DRUG; VACCINE; VINCAXOME; VINCRISTINE; VIRUS VACCINE;

BIODEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; LIPID BILAYER; LIPID VESICLE; NONHUMAN; REVIEW; VETERINARY MEDICINE;

AVES; AVIAN ORTHOREOVIRUS; BACTERIA (MICROORGANISMS); REOVIRUS SP.;

EID: 7344232179     PISSN: 09284249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Abu-Salah K.M., Amphotericin B: An update, Br. J. Biomed. Sci. 53 (1996) 122-133.
2. Akbarieh M., Besner J.G., Galal A., Tawashi R., Liposomal delivery system for the targeting and controlled release of praziquantel, Drug Dev. Ind. Pharm. 18 (1992) 303-317.
3. Allen T.M., Long-circulating (sterically stabilized) liposomes for targeted drug delivery, Trends Pharmacol. Sci. 15 (1994) 215-220.
4. Allen T., Austin G.A., Chonn A., Lin L., Lee K.C., Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim. Biophys. Acta 1061 (1991) 56-64.
5. Allen T., Hansen C.B., Peliowski A., Subcutaneous administration of sterically stabilized (Stealth) liposomes. Is an effective sustained release system for Iβ-D-arabinofuranosylcytosine. Drug Delivery 1 (1993) 55-60.
6. Aramaki Y., Suda H., Tsuchiya S., Interferongamma inductive effect of liposomes as an immunoadjuvant. Vaccine 13 (1996) 1809-1814.
7. Baeza I., Wong C., Mondragon R., González S., Ibañez M., Farfan N., Argello C., Transbilayer diffusion of divalent cations into liposomes mediated by lipidic particles of phosphatidate, J. Mol. Evol. 39 (1994) 560-568.
8. Baker R.R., Czopf L., Tilling T., Freeman B.A., Kirk K.L., Matalon S., Quantitation of alveolar distribution of liposome-entrapped antioxidant enzymes, Am. J. Physiol. 263 (1992) L585-594.
9. Berman J.D., Experimental chemotherapy of leishmaniasis - a critical review, in: Chang/Bray (Eds.), Leishmaniasis, Elsevier, Amsterdam, 1985, pp. 111-138.
10. Bhamra R., Saád A., Bolcsak L.E., Janoff A.S., Swenson C.E., Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats, Antimicrob. Agents Chemother. 41 (1997) 886-892.
11. Bloemen P.G.M., Henriks F.A.S., Vanbloois L., Vandentweel M.C., Nijkamp P.P., Crommelin D.J.A., Storm G., Adhesion molecules: A new target for immunoliposome-mediated drus delivery, FEBS Lett. 357 (1995) 140-144.
12. Bloom J.D., Hamor R.E., Gerding P.A., Ocular blastomycosis in dogs: 73 cases, 108 eyes (1985-1993), J. Am. Vet. Med. Assoc. 209 (1996) 1271-1274.
13. Böhme A., Hoelzer D., Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients, Mycoses 30 (1996) 419-426.
14. Cabanes A., Reig F., Garcia Anton J.M., Arboix M., Sustained release of liposome encapsulated enrofloxacin after intramuscular administration in rabbits, Am. J. Vet. Res. 56 (1995) 1498-1501.
15. Chow C.Y., Heath T.D., Rapid diffusion of the lipid phosphorus of phosphatidylglycerol liposomes through polycarbonate membranes is caused by the oxidation of the unsaturated fatty acids, Biochim. Biophys. Acta-Biomembranes 1239 (1995) 168-176.
16. Conley J., Yang H., Wilson T., Blasetti K., Di Ninno V., Schnell G., Wong J.P., Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice, Antimicrob. Agents Chemother. 41 (1997) 1288-1292.
17. Croft S.L., Liposomes in the treatment of parasitic diseases, Pharmacy Int. (1986) 229-233.
18. Cynamon M.H., Swenson C.E., Palmer G.S., Ginsberg R.S., Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice, Antimicrob. Agents Chemother. 33 (1989) 1179-1183.
19. Daemen T., Hofstede G., Ten Kate M.T., Bakker-Woudenberg I.A.J.M., Scherphof G., Liposomal doxorubicin-induced toxicity: Depletion and impairment of phagocytic activity of liver macrophages, Int. J. Cancer 61 (1995) 716-721.
20. Daemen T., Regts J., Meesters M., Ten Kate M.T., Bakker-Woudenberg I.A.J.M., Scherphof G.L., Toxicity of doxorubicin entrapped within long-circulating liposomes, J. Control. Release 44 (1997) 1-9.
21. Davidson R.N., di Martino L., Gradoni L., Giacchino R., Gaeta G.B., Pempinello R., Scotti S., Cascio A., Castagnola E., Maisto A., Gramiccia M., di Caprio D., Wilkinson R.J., Bryceson A.D., Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome), Clin. Infect. Dis. 22 (1996) 938-943.
22. Domingo S., Gastearena Y., Vitas A.I., López-Goñi I., Dios-Viétez C., Díaz R., Gamazo C., Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. J. Antimicrob. Chemother. 36 (1995) 647-656.
23. Dousset N., Douste-Blazy L., Méthodes de préparation des liposomes, in : Puisieux F., Delattre J. (éd.). Les liposomes. Applications thérapeutiques. Technique et Documentation-Lavoisier, Paris, 1985, pp. 41-72.
24. Escher B.I., Schwarzenbach R.P., Partitioning of substituted phenols in liposome-water, biomembranes and octanol-water systems. Environ. Sci. Technol. 30 (1996) 260-270.
25. Fendler J.H., Optimizing drug entrapment in liposomes. Chemical and biophysical considerations, in: Gregoriadis G., Allison A.C. (Eds.), Liposomes in Biolosical Systems. J. Wiley & Sons, Chichester, 1980, pp. 87-99.
26. Fortin A., Shahua E., Krzystymak K., Thenen H.M., Differential activation of cell-mediated immune functions by encapsulated and surface-linked liposomal antigens. Cell Immunol. 169 (1996) 208-217.
27. Fusai T., Durand R., Boulard Y., Paul M., Bories C., Rivolett D., Houin R., Deniau M., Importance of drug carriers in the treatment of visceral leishmaniasis, Med. Trop. 55 (1995) 73-78.
28. Gabizon A., Papahadjopoulos D., The role of surface charge and hydrophilic groups on liposome clearance in vivo, Biochim. Biophys. Acta 1103 (1992) 94-100.
29. Gabizon A., Isacson R., Libson E., Kaufman B., Uziely B., Catane R., Bendor C.G., Rabello E., Cass Y., Peretz T., Sulkes A., Chisin R., Barenholz Y., Clinical studies of liposome-encapsulated doxorubicin, Acta Oncologica 33 (1994) 779-786.
30. Galligioni E., Santarosa M., Favaro D., Spada A., Talamini R., Quaia M., In vitro synergic effect of interferon gamma combined with liposomes containing muramyl tripeptide in human monocyte cytotoxicity against fresh allogeneic and autologous tumor cells, Tumori 80 (1994) 385-391.
31. Gangneux J.-P., Sulahian A., Garin Y.J.-F., Farinotti R., Derouin F., Therapy of visceral leishmaniasis due to Leishmania infantum: Experimental assessment of efficacy of AmBisome, Antimicrob. Agents Chemother. 40 (1996) 1214-1218.
32. Gangneux J.-P., Sulahian A., Garin Y.J., Derouin F.F., Lipid formulations of amphotericin B in the treatment of experimental visceral leishmaniasis due to Leishmania infantum, Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 574-577.
33. Gasanov S.E., Rael E.D., Martínez M., Baeza G., Vernon L.P., Modulation of phospholipase A(2) activity by membrane-active peptides on liposomes of different phospholipid composition. Gen. Physiol. Biophys. 13 (1994) 275-286.
34. Goldbach P., Dumont S., Kessler R., Poindron P., Stamm A., In situ activation of mouse alveolar macrophages by aerosolized liposomal IFN-gamma and muramyl tripeptide. Am. J. Physiol.-Lung Cell M. Ph. 14 (1996) L429-L434
35. Gondal J.A., Swartz R.P., Rahman A., Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice, Antimicrob. Agents Chemother. 33 (1989) 1544-1548.
36. Graybill J.R., Bocanegra R., Liposomal amphotericin B therapy of murine histoplasmosis, Antimicrob. Agents Chemother 39 (1995) 1885-1887.
37. Grayson L.S., Hansbrough J.F., Zapata-Sirvent R., Roehrborn A.J., Kim T., Kim S., Soft tissue prophylaxis with gentamicin encapsulated in multivesicular liposomes: results from a prospective, randomized trial, Crit. Care. Med. 23 (1995) 84-91.
38. Gregoriadis G., Immunological adjuvants: a role for liposomes, Immunol. Today 11 (1990) 89-97.
39. Gregoriadis G., Engineering liposomes for drug delivery: Progress and problems. TIBTECH 13 (1995) 527-537.
40. Hansen C.B., Kao G.Y., Moase E.H., Zalipsky S., Allen T.M., Attachment of antibodies to sterically stabilized liposomes: Evaluation, comparison, and optimization of coupling procedures, Biochim. Biophys. Acta-Biomembranes 1239 (1995) 133-144.
41. Hartsel S., Bolard J., Amphotericin B: new life for an old drus. Trends Pharmacol. Sci. 17 (1996) 445-449.
42. Hauser H., Phase behaviour of Charged Lipids, in: Bangham A.D. (Ed.). Liposome Letters, Academic Press. London, 1983, pp 49-62.
43. Heinemann V., Bosse D., Jehn U., Kähny B., Wachhloz K., Debus A., Scholz P., Kolb HJ., Wilmanns W., Pharmacokmetics of liposomal amphotericin B (AmBisome) in critically ill patients. Antimicrob. Agents Chemother. 41 (1997) 1275-1280.
44. Hermanm E.H., Rahman A., Ferrans V.J., Vick I.A., Schein P.S., Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation, Cancer Res. 43 (1983) 5427-5432.
45. Hospenthal D.R., Rogers A.L., Beneke E.S., Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis, Antimicrob. Agents Chemother. 33 (1989) 16-18.
46. Ivanoff N., Phillips N., Schacht A.M., Heydari C., Capron A., Riveau G., Mucosal vaccination against schistosomiasis using liposome-associated Sm28kDa glutathione S-transferase, Vaccine 14 (1996) 1123-1131.
47. Kakinuma K., Tanaka R., Takahashi H., Sekihara Y., Watanabe M., Kuroki M., Drug delivery to the brain using thermosensitive liposome and local hyperthermia. Int. J. Hyperthermia 12 (1996) 157-165.
48. Kende M., Alving C.R., Rill W.L., Swartz G.M., Canonico PG., Enhanced efficacy of liposome-encapsulated ribavarin against Rift Valley Fever virus infection in mice, Antimicrob. Agents Chemother. 27 (1985) 903-907.
49. Kisseberth W.C., McEwen E.G., Helfand S.C., Vail D.M., London C.L., Keller E., Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma, J. Vet. Intern. Med. 9 (1995) 425-428.
50. Koff W.C., Fidler I.J., The potential use of liposome-mediated antiviral therapy. Antiviral Res. 5 (1985) 179-190.
51. Kono K., Igawa T., Takagishi T., Cytoplasmic delivery of calcein mediated by liposomes modified with pH-sensitive poly(ethylene glycol) derivative, Biochim. Biophys. Acta 1325 (1997) 143-154.
52. Krawiec D.R., McKiernan B.C., Twardock A.R., Swenson C.E., Itkin R.J., Johnson L.R., Kurowsky L.K., Marks C.A., Use of an amphotericin B lipid complex for treatment of blastomycosis in dogs, J. Am. Vet. Assoc. 209 (1996) 2073-2075.
53. Lambros M.P., Bourne D.W., Abbas S.A., Johnson D.L., Disposition of aerosolized liposomal amphotencin B, J. Pharm. Sci. 86 (1997) 1066-1069.
54. Lasic D.D., Ceh B., Stuart M.C.A., Guo L., Frederik P.M., Barenholz Y., Transmembrane gradient driven phase transitions within vesicles: Lessons for drug delivery, Biochim. Biophys. Acta-Biomembranes 1239 (1995) 145-156.
55. Lawaczeck R., Engelbert H.P., Water permeabilitys of liposomes. Early experiments and a new method, in: Bangham A.D. (Ed.), Liposome Letters, Academic Press, London, 1983, pp. 113-120.
56. Leconte P., Legallou F., Potel G., Struillou L., Baron D., Dugeon H.B., Pharmacokinetics, toxicity and efficacy of liposomal capreomycin in disseminated Mycobacterium avium in beige mouse model, Antimicrob. Agents Chemother. 38 (1994) 2695-2701.
57. Leenders A.C., de Marie S., Ten Kate M.T., Bakker-Woundenberg I.A., Verbrugh H.A., Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis, J. Antimicrob. Chemother. 38 (1996) 215-225.
58. Liu F., Liu D., Serum independent liposome uptake by mouse liver, Biochim. Biophys. Acta 1278 (1996) 5-11.
59. Liu D., Song Y.K., Liu F., Antibody dependent, complement mediated liver uptake of liposomes contaizning GM(1). Pharmaceut. Res. 12 (1995) 1776-1780.
60. Liu D., Hu Q., Song Y.K., Liposome clearance from blood: different animal species have different mechanisms, Biochim. Biophys. Acta 1240 (1995) 277-284.
61. López O., Delamaza A., Coderch L., Parra J.L., Formation and characterization of liposomes from lipid protein material extracted from pis stratum corium, J. Am. Oil Chem. Soc 73 (1996) 443-448.
62. MacDonald R.I., Oku N., MacDonald R.C., Liposome formation. Re-visited, in: Bangham A.D. (Ed.), Liposome Letters, Academic Press, London, 1983, pp. 63-72.
63. MacEwen E.G., Kurzrnan I.D., Rosenthal R.C., Smith B.W., Manley P.A., Roush J.K., Howard P.E., Therapy for osteosarcoma in dogs with IV injection of liposome encapsulated muramyl tripeptide, J. Nail. Cancer Inst. 81 (1989) 935-938.
64. MacLeod D.L., Prescott J.F., The use of liposomally-entrapped gentamicin in the treatment of bovine Staphylococcus aureus mastitis, Can. J. Vet. Res. 52 (1988) 445-450.
65. Makabipanzu B., Lessard C., Perron S., Desorneaux A., Tremblay M., Poulin L., Beauchamp D., Bergeron M.G., Comparison of cellular accumulation, tissue distribution, and anti-HIV activity of free and liposomal 2′,3′-dideoxycytidine, AIDS Res. Hum. Retroviruses 10 (1994) 1463-1470.
66. Micklus M.J., Greig N.H., Tung J., Rapaport S.I., Targeting of liposomes to the blood-brain barrier in rats. Drug Delivery 1 (1993) 21-26.
67. Moghimi S.M., Patel H.M., Altered tissue-specific opsonic activities and opsono-recognition of liposomes in tumour-bearins rats, Biochim. Biophys. Acta 1285 (1996) 56-64.
68. Myers M.A., Thomas D.A., Straub L., Soucy D.W., Niven R.W., Kaltenbach M., Hood C.I., Schreier H., Gonzalez-Rothi R.J., Pulmonary effects of chronic exposure to liposome aerosols in mice, Exp. Lung Res. 19 (1993) 1-19.
69. Naito S., Horino A., Nakayama M., Nakano Y., Nagai T., Mizuguchi J., Komuro K., Uchida T., Ovalbumin-liposome conjugate induces IgG but not IgE antibody production, Int. Arch. Allergy Immunol. 109 (1996) 223-228.
70. Nakamura K., Kubo A., Datayama M., Hashimoto S., Takatoku K., Wakui Y., Bando K., Indium-111-labeled liposomes: quality and biodistribution in mice bearing human tumor xenografts, Drug Delivery 1 (1993) 69-73.
71. New R.R.C., Wen H., Craig P.S., Zou P.P., Merdan A., Wang J.H., Wang Y.H , Wang, P., Zhang J.H., Efficacy of albendazole administered orally is improved by encapsulation in liposomes, J. Control. Rel. 28 (1994) 350-351.
72. Nicoletti P., Milward F.W., Hoffman E., Altvater L., Efficacy of a long-acting oxytetracycline alone or combined with streptomycin in the treatment of bovine brucellosis. J. Am. Vet. Med. Assoc. 187 (1985) 493-495.
73. Nicoletti P., Lenk R.P., Popescu M.C., Swenson C.E., Efficacy of various treatment regimens using liposomal streptomycin in cows with brucellosis. Am. J. Vet. Res. 50 (1989) 1004-1007.
74. Nichols J.W., Proton-Hydroxide Permeability of Liposomes, in: Bangham A.D. (Ed.), Liposome Letters, Academic Press, London, 1983, pp. 121-126.
75. Oliva G., Gradioni L., Ciaramella P., De Luna R., Cortese L., Orsini S., Davidson R.N., Persechino A., Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum. J Antimicrob. Chemother. 36 (1995) 1013-1019.
76. Ogihara-Umeda Y., Kojima S., Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumours, Eur. J. Nucl. Med. 15 (1989) 612-617.
77. Panasenko O.M., Arnhold J., Schiller J., Arnold K., Sergienko V.J., Peroxidation of egg yolk phosphatidylcholine liposomes by hypochlorus acid, Biochim. Biophys. Acta Lipid Lipid Metab. 1215 (1994) 259-266.
78. Panasenko O.M., Arnhold J., Mechanism of hypochlorite-induced peroxidation in phospholipid liposomes, Biol. Membrany 13 (1996) 89-99.
79. Paula S., Volkov A.G., Vanhoek A.N., Haines T.H., Deamer D.W., Permeation of protons, Potassium ions, and small polar molecules through phosphohpid bilayers as a function of membrane thickness. Biophysics J. 70 (1996) 339-348.
80. Paul M., Durand R., Fessi H., Rivolett D., Houin R., Astier A., Deniau M., Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a marine model, Antimicrob. Agents Chemother. 41 (1997) 1734-1734.
81. Peregrine, A.S., Chemotherapy and delivery systems: haemoparasites. Vet. Parasitol. 54 (1994) 223-248.
82. Perrett S., Golding M., Williams W.P., A simple method for the preparation of liposomes for pharmaceutical applications: characterization of the liposomes, J. Pharm. Pharmacol. 43 (1991) 154-161.
83. Poste G., Liposomes: fascination, frustration, feasibility, and fantasy, in: Bangharn A.D. (Ed.), Liposome Letters, Academic Press, London, 1983, pp. 375-386.
84. Prescott J.F., Baggot J.D., Antimicrobial Therapy in Veterinary Medicine, 2nd ed., ISU Press, Iowa, 1993.
85. Privitea N., Naon R., Riess J.G., Hydrolysis of DMPC or DPPC by pancreatic phospholipase A(2) is slowed down when (perfluoroalkyl) alkanes are incorporated into the liposomal membrane, Biochim. Biophys. Acta - Lipid Lipid Metab. 1254 (1995) 1-6.
86. Rahman Y.E., Liposomes as carriers for shelters, in: Bangham A.D. (Ed.), Liposome Letters, Academic Press, London, 1983, pp. 335-340.
87. Ramos H., Braitburg J., Márquez V., Cohen B.E., Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin bile salt mixed micelles. Drug Exp. Clin. Res. 21 (1995) 211-215.
88. Reilly L.K., Palmer J.E., Systemic candidiasis in four foals, J. Am. Vet. Med. Assoc. 205 (1994) 464-466.
89. Ropert C., Lavignon M., Dubernet C., Couvreur P., Malvy C., Oligonucleotides encapsulated in pH-sensitive liposomes are efficient toward Friend retrovirus, Bichem. Biophys. Res. Comm. 183 (1992) 879-885
90. Ropert C., Malvy C., Couvreur P., Inhibition of the Friend retrovirus by antisense oligonucleotides encapsulated in liposomes: mechanism of action, Pharm. Res. 10 (1993) 1427-1433.
91. Ropert C., Okruszek A., Couvreur P., Malvy C., Retroviral inhibition by antisense oligonucleotides determined by mtracellular stability, Antisense Res. Dev. 4 (1994) 207-210.
92. Ropert C., Mishal Z. Jr. Rodrigues J.M., Malvy C., Couvreur P., Retrovirus budding may constitute a port of entry for drug carriers, Biochim. Biophys. Acta 1310 (1997) 53-59.
93. Ruenwongsa P., Thamavit W., Increased efficacy of liposome-encapsulated praziquantel in treatment of opistorchiasis in hamsters, Southeast Asian 3. Trop. Med. Public Health 14 (1983) 501-504.
94. Ryman BE., Liposomes - Thoughts on targeting, in: Bangham A.D., Liposome Letters, Academic Press, London, 1983, pp. 341-356.
95. Schroeder R., London E., Brown D., Interactions between saturated acyl chains confer detergents resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behaviour, Proc. Nat. Acad. Sci. USA 91 (1994) 12130-12134.
96. Sela S., Husain S.R., Pearson J.W., Longo D.L., Rahman A., Reversal of multi-drug resistance in human colon cancer cells expressing the human MDRI gene by liposomes in combination with monoclonal antibody or verapamil, J. Natl. Cancer Inst. 87 (1995) 123-128.
97. Shahinian S., Silvius J.R., A novel strategy affords high-yield coupling of antibody Fab' fragments to liposomes. Biochim. Biophys. Acta - Biomembranes 1239 (1995) 157-167.
98. Shaw I.H., Dingle J.T., Liposomes as steroid carriers in the intra-articular therapy of rheumatoid arthritis, in: Gregoriadis G., Allison A.C. (Eds.), Liposomes in Biological Systems, J. Wiley & Sons, Chichester, 1980, pp. 299-323.
99. Sundar S., Murray H.W., Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex, J. Infect. Dis. 173 (1996) 762-765.
100. Strazhenskikh A.N., Molovka O.A., Chabanov M.K., Bychkov V.G., Iarotskii L.S., A comparative study of the efficacy of praziquantel and its liposomal form in experimental opistorchiasis, Med. Parazitol. Parazit. Bolezni 4 (1990) 39-41.
101. Swenson C.E., Popescu M.C., Ginsberg R.S., Preparation and use of liposomes in the treatment of microbial infections, Crit. Rev. Microbiol. 15 (1988) (suppl. 1), s1-s31.
102. Szoka F., Papahadjopoulos D., Comparative properties and methods of preparation of lipid vesicles (liposomes), Annu. Rev. Biophys. Bioeng. 9 (1980) 467-508.
103. Talsma H., van Steenbergen M.J., Borchert J.C., Crommelin D.J., A novel technique for the one-step preparation of liposomes and nonionic surfactant vesicles without the use of organic solvents. Liposome formation in a continous gas stream: the "bubble" method, J. Pharm. Sci. 83 (1994) 276-280.
104. van Etten E.W., Otte-Lambillion M., van Vianen W., ten Kate M.T., Bakker-Woudenberg A.J., Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizome) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans, J. Antimicrob. Chemother. 35 (1995) 509-519.
105. Velebny S., Hrckova G., The effect of free and liposome-entrapped praziquantel in serum activity of aminotransferases in mice infected with mesocestoides corti tetrahyridia, Helminthologia 32 (1995) 193-199.
106. Vitas A.I., Díaz R., Gamazo C., Protective effect of liposomal gentamicin against systemic acute murine brucellosis, Chemotherapy 43 (1997) 204-210.
107. Vuillemard J.C., Recent advances in the large-scale production of lipid vesicles for use in food products: microfluidization, J. Microencapsulation 8 (1991) 547-562.
108. Weissmann G., Finkekstein M., Uptake of enzyme-bearing liposomes by cells in vivo and in vitro, in: Gregoriadis G., Allison A.C. (Eds.), Liposomes in Biological Systems, Wiley & Sons, Chichester, 1980, pp. 153-174.
109. Weissmann G., Serhan C., Liposomes as membranes models for the discovery of endogenous calcium ionophores, in: Bangham A.D. (Ed.), Liposome Letters, Academic Press, London, 1983, pp. 137-145.
110. Wen H., New R.R., Muhmut M., Wang J.H., Wang Y.H., Zhang J.H., Shao Y.M., Craig P.S., Pharmacological and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine, Parasstology 113 (1996) 111-121.
111. Woodle M.C., Newman M.S., Cohen J.A., Sterically stabilized liposomes: physical and biological properties, J. Drug Targeting 2 (1994) 397-403.
112. Yardley V., Croft S.L., Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis, Antimicrob. Agents Chemother. 41 (1997) 752-756.
113. Yang Y.-S., Fung K.F., Preparation of albendazole liposomes and its effect on Fasciola hepatica in goats, Acta Vet. Scand. Suppl. 87 (1992) 406-407.
114. Yang Y., Ou Y., Ruan C., Cheng Y., Zhang F., (1994) Trypanocidal value of liposomal diminazene in experimental Trypanosoma brucei evansi infection in mice, Proc. 6th EAVPT Congress, Scotland, 1994, pp. 264-265.
115. Yoshida Y., Kashiba K., Niki E., Free radical-mediated oxidation of lipids induced by hemoglobin in aqueous dispersions, Biochim. Biophys. Acta - Gen. Subject 1201 (1994) 165-172.